632 related articles for article (PubMed ID: 16107576)
1. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.
Wharram BL; Goyal M; Wiggins JE; Sanden SK; Hussain S; Filipiak WE; Saunders TL; Dysko RC; Kohno K; Holzman LB; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2941-52. PubMed ID: 16107576
[TBL] [Abstract][Full Text] [Related]
2. Podocyte hypertrophy, "adaptation," and "decompensation" associated with glomerular enlargement and glomerulosclerosis in the aging rat: prevention by calorie restriction.
Wiggins JE; Goyal M; Sanden SK; Wharram BL; Shedden KA; Misek DE; Kuick RD; Wiggins RC
J Am Soc Nephrol; 2005 Oct; 16(10):2953-66. PubMed ID: 16120818
[TBL] [Abstract][Full Text] [Related]
3. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis.
Zuo Y; Matsusaka T; Zhong J; Ma J; Ma LJ; Hanna Z; Jolicoeur P; Fogo AB; Ichikawa I
J Am Soc Nephrol; 2006 Oct; 17(10):2832-43. PubMed ID: 16988066
[TBL] [Abstract][Full Text] [Related]
5. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.
Macconi D; Bonomelli M; Benigni A; Plati T; Sangalli F; Longaretti L; Conti S; Kawachi H; Hill P; Remuzzi G; Remuzzi A
Am J Pathol; 2006 Jan; 168(1):42-54. PubMed ID: 16400008
[TBL] [Abstract][Full Text] [Related]
7. [Role of podocyte damage in the pathogenesis of glomerulosclerosis and tubulointerstitial lesions: findings in the growth hormone transgenic mouse model of progressive nephropathy].
Wanke R; Wolf E; Brem G; Hermanns W
Verh Dtsch Ges Pathol; 2001; 85():250-6. PubMed ID: 11894406
[TBL] [Abstract][Full Text] [Related]
8. Growth-dependent podocyte failure causes glomerulosclerosis.
Fukuda A; Chowdhury MA; Venkatareddy MP; Wang SQ; Nishizono R; Suzuki T; Wickman LT; Wiggins JE; Muchayi T; Fingar D; Shedden KA; Inoki K; Wiggins RC
J Am Soc Nephrol; 2012 Aug; 23(8):1351-63. PubMed ID: 22773827
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.
Fukuda A; Wickman LT; Venkatareddy MP; Sato Y; Chowdhury MA; Wang SQ; Shedden KA; Dysko RC; Wiggins JE; Wiggins RC
Kidney Int; 2012 Jan; 81(1):40-55. PubMed ID: 21937979
[TBL] [Abstract][Full Text] [Related]
10. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
[TBL] [Abstract][Full Text] [Related]
11. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria.
Yu D; Petermann A; Kunter U; Rong S; Shankland SJ; Floege J
J Am Soc Nephrol; 2005 Jun; 16(6):1733-41. PubMed ID: 15829708
[TBL] [Abstract][Full Text] [Related]
12. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat.
Kim YH; Goyal M; Kurnit D; Wharram B; Wiggins J; Holzman L; Kershaw D; Wiggins R
Kidney Int; 2001 Sep; 60(3):957-68. PubMed ID: 11532090
[TBL] [Abstract][Full Text] [Related]
13. Modulation of podocyte phenotype in collapsing glomerulopathies.
Barisoni L; Kopp JB
Microsc Res Tech; 2002 May; 57(4):254-62. PubMed ID: 12012394
[TBL] [Abstract][Full Text] [Related]
14. Podocyte injury in focal segmental glomerulosclerosis: Lessons from animal models (a play in five acts).
D'Agati VD
Kidney Int; 2008 Feb; 73(4):399-406. PubMed ID: 17989648
[TBL] [Abstract][Full Text] [Related]
15. Mechanical strain increases SPARC levels in podocytes: implications for glomerulosclerosis.
Durvasula RV; Shankland SJ
Am J Physiol Renal Physiol; 2005 Sep; 289(3):F577-84. PubMed ID: 16093428
[TBL] [Abstract][Full Text] [Related]
16. [Podocyte injury and glomerular sclerosis].
Matsusaka T
Nihon Rinsho; 2004 Oct; 62(10):1805-10. PubMed ID: 15500122
[TBL] [Abstract][Full Text] [Related]
17. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
Celik Y; Celik F
Transl Res; 2006 Jul; 148(1):46. PubMed ID: 16887498
[No Abstract] [Full Text] [Related]
18. Chronic Masugi nephritis in the rat. An electron microscopic study on evolution and consequences of glomerular capsular adhesions.
Kondo Y; Akikusa B
Acta Pathol Jpn; 1982 Mar; 32(2):231-42. PubMed ID: 7090815
[TBL] [Abstract][Full Text] [Related]
19. [The role of podocyte injury in chronic kidney disease].
Asanuma K
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin prevents podocyte injury in a murine model of HIV-associated nephropathy.
Sakurai N; Kuroiwa T; Ikeuchi H; Hiramatsu N; Takeuchi S; Tomioka M; Shigehara T; Maeshima A; Kaneko Y; Hiromura K; Kopp JB; Nojima Y
Nephrol Dial Transplant; 2009 Aug; 24(8):2378-83. PubMed ID: 19188342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
